Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Lillicrap

Showing results (181-190 of 216) with videos related to

Pageof 22
Sort By:
Blood Advances|July 8, 2018
The common <i>VWF</i> single nucleotide variants c.2365A>G and c.2385T>C modify VWF biosynthesis and clearanceAhmad H Mufti, Kenichi Ogiwara, Laura L Swystun, et al.
Blood|September 30, 2010
Eradication of neutralizing antibodies to factor VIII in canine hemophilia A after liver gene therapyJonathan D Finn, Margareth C Ozelo, Denise E Sabatino, et al.
Blood|December 28, 2006
The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort studyPaula D James, Colleen Notley, Carol Hegadorn, et al.
Journal of Thrombosis and Haemostasis : JTH|March 16, 2025
Corticosteroid use to mitigate transaminitis-associated decline in FVIII levels following valoctocogene roxaparvovec gene therapy: clinical practice guidanceBarbara A Konkle, Flora Peyvandi, Graham R Foster, et al.
Journal of Thrombosis and Haemostasis : JTH|July 12, 2024
R1205H (Vicenza) causes conformational changes in the von Willebrand factor D'D3 domains and enhances von Willebrand factor binding to clearance receptors LRP1 and SR-AIFerdows Atiq, Orla Rawley, Jamie M O'Sullivan, et al.
Thrombosis and Haemostasis|January 28, 2021
A Practical, One-Clinic Visit Protocol for Pharmacokinetic Profile Generation with the ADVATE myPKFiT Dosing Tool in Severe Hemophilia A SubjectsVictor S Blanchette, Laura Zunino, Viviane Grassmann, et al.
Blood Advances|February 9, 2021
Molecular coevolution of coagulation factor VIII and von Willebrand factorPhilip M Zakas, Christopher W Coyle, Anja Brehm, et al.
The Journal of Clinical Investigation|August 21, 2018
The endothelial cell receptor stabilin-2 regulates VWF-FVIII complex half-life and immunogenicityLaura L Swystun, Jesse D Lai, Colleen Notley, et al.
Blood|March 7, 2024
Vector integration and fate in the hemophilia dog liver multiple years after AAV-FVIII gene transferPaul Batty, Sylvia Fong, Matteo Franco, et al.
Blood|March 9, 2006
Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogsHaiyan Jiang, David Lillicrap, Susannah Patarroyo-White, et al.
Pageof 22

Showing results (181-190 of 216) with videos related to

Sort By:
Pageof 22
Blood Advances|July 8, 2018
The common <i>VWF</i> single nucleotide variants c.2365A>G and c.2385T>C modify VWF biosynthesis and clearanceAhmad H Mufti, Kenichi Ogiwara, Laura L Swystun, et al.
Blood|September 30, 2010
Eradication of neutralizing antibodies to factor VIII in canine hemophilia A after liver gene therapyJonathan D Finn, Margareth C Ozelo, Denise E Sabatino, et al.
Blood|December 28, 2006
The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort studyPaula D James, Colleen Notley, Carol Hegadorn, et al.
Journal of Thrombosis and Haemostasis : JTH|March 16, 2025
Corticosteroid use to mitigate transaminitis-associated decline in FVIII levels following valoctocogene roxaparvovec gene therapy: clinical practice guidanceBarbara A Konkle, Flora Peyvandi, Graham R Foster, et al.
Journal of Thrombosis and Haemostasis : JTH|July 12, 2024
R1205H (Vicenza) causes conformational changes in the von Willebrand factor D'D3 domains and enhances von Willebrand factor binding to clearance receptors LRP1 and SR-AIFerdows Atiq, Orla Rawley, Jamie M O'Sullivan, et al.
Thrombosis and Haemostasis|January 28, 2021
A Practical, One-Clinic Visit Protocol for Pharmacokinetic Profile Generation with the ADVATE myPKFiT Dosing Tool in Severe Hemophilia A SubjectsVictor S Blanchette, Laura Zunino, Viviane Grassmann, et al.
Blood Advances|February 9, 2021
Molecular coevolution of coagulation factor VIII and von Willebrand factorPhilip M Zakas, Christopher W Coyle, Anja Brehm, et al.
The Journal of Clinical Investigation|August 21, 2018
The endothelial cell receptor stabilin-2 regulates VWF-FVIII complex half-life and immunogenicityLaura L Swystun, Jesse D Lai, Colleen Notley, et al.
Blood|March 7, 2024
Vector integration and fate in the hemophilia dog liver multiple years after AAV-FVIII gene transferPaul Batty, Sylvia Fong, Matteo Franco, et al.
Blood|March 9, 2006
Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogsHaiyan Jiang, David Lillicrap, Susannah Patarroyo-White, et al.
Pageof 22